Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
OPERATING EXPENSES
Research and development	$ 1,012,085	$ 1,657,838	$ 2,494,490	$ 3,024,779
General and administrative	622,347	711,360	1,127,819	1,383,517
Total operating expenses	1,634,432	2,369,198	3,622,309	4,408,296
LOSS FROM OPERATIONS	(1,634,432)	(2,369,198)	(3,622,309)	(4,408,296)
OTHER INCOME (EXPENSE):
Interest income	784	15,565	6,001	37,749
Interest expense	(4,131)	0	(4,131)	0
Loss on issuance of Series A preferred stock for accounts payable - related party	(142,669)	0	(142,669)	0
Change in fair value of derivative	(147,078)	122,541	274,449	298,092
Other (expense) income	(293,094)	138,206	133,650	335,841
LOSS BEFORE INCOME TAX PROVISION	(1,927,526)	(2,230,992)	(3,488,659)	(4,072,455)
INCOME TAX PROVISION	0	0	0	0
NET LOSS	$ (1,927,526)	$ (2,230,992)	$ (3,488,659)	$ (4,072,455)
NET LOSS PER COMMON SHARE
Net loss per common share- basic and diluted	$ (0.50)	$ (0.64)	$ (0.91)	$ (1.18)
Weighted average common shares outstanding
Weighted average common shares outstanding- basic and diluted	3,853,858	3,469,193	3,849,437	3,464,246